Log in

OTCMKTS:CRPOFCeapro Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $0.40
50-Day Range
MA: $0.31
52-Week Range
Now: $0.40
Volume180 shs
Average Volume4,314 shs
Market Capitalization$31.04 million
P/E RatioN/A
Dividend YieldN/A
Ceapro, Inc. is a biotechnology company, which is involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its extracts are also used in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company specializes in natural product chemistry, microbiology, biochemistry, immunology, and process engineering in the fields of active ingredients, biopharmaceuticals, and drug-delivery solutions. Ceapro was founded on January 1, 1997 and is headquartered in Edmonton, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations



Sales & Book Value

Annual Sales$9.71 million
Book Value$0.22 per share


Net Income$-850,000.00


Market Cap$31.04 million
Next Earnings Date8/26/2020 (Estimated)
OptionableNot Optionable

Receive CRPOF News and Ratings via Email

Sign-up to receive the latest news and ratings for CRPOF and its competitors with MarketBeat's FREE daily newsletter.

Ceapro (OTCMKTS:CRPOF) Frequently Asked Questions

How has Ceapro's stock been impacted by COVID-19 (Coronavirus)?

Ceapro's stock was trading at $0.1909 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CRPOF shares have increased by 109.5% and is now trading at $0.40. View which stocks have been most impacted by Coronavirus.

When is Ceapro's next earnings date?

Ceapro is scheduled to release its next quarterly earnings announcement on Wednesday, August 26th 2020. View our earnings forecast for Ceapro.

How were Ceapro's earnings last quarter?

Ceapro Inc (OTCMKTS:CRPOF) released its earnings results on Thursday, May, 28th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $3.19 million for the quarter. Ceapro had a net margin of 4.48% and a return on equity of 2.78%. View Ceapro's earnings history.

Has Ceapro been receiving favorable news coverage?

Press coverage about CRPOF stock has been trending negative on Monday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Ceapro earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Ceapro.

Who are some of Ceapro's key competitors?

Who are Ceapro's key executives?

Ceapro's management team includes the following people:
  • Gilles R. Gagnon, President, Chief Executive Officer & Director
  • Stacy Prefontaine, Chief Financial Officer & Secretary
  • Leoni DeJoya, Vice President-Bioprocessing Business Unit

What is Ceapro's stock symbol?

Ceapro trades on the OTCMKTS under the ticker symbol "CRPOF."

How do I buy shares of Ceapro?

Shares of CRPOF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ceapro's stock price today?

One share of CRPOF stock can currently be purchased for approximately $0.40.

How big of a company is Ceapro?

Ceapro has a market capitalization of $31.04 million and generates $9.71 million in revenue each year.

What is Ceapro's official website?

The official website for Ceapro is www.ceapro.com.

How can I contact Ceapro?

Ceapro's mailing address is 7824 51 Avenue NW, Edmonton A0, T6E 6W2. The company can be reached via phone at 780-421-4555 or via email at [email protected]

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.